These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 4066504)
1. Microbial conversion of daunorubicin into N-acetyl-13(S)-dihydrodaunomycin and bisanhydro-13-dihydrodaunomycinone. Dornberger K; Hübener R; Ihn W; Thrum H; Radics L J Antibiot (Tokyo); 1985 Sep; 38(9):1219-25. PubMed ID: 4066504 [TBL] [Abstract][Full Text] [Related]
2. Microbial conversion of epsilon-pyrromycinone and epsilon-isorhodomycinone to 1-hydroxy-13-dihydrodaunomcyin and N-formyl-1-hydroxy-13-dihydrodaunomycin and their bioactivities. Yoshimoto A; Matsuzawa Y; Oki T; Naganawa H; Takeuchi T; Umezawa H J Antibiot (Tokyo); 1980 Oct; 33(10):1150-7. PubMed ID: 7451366 [TBL] [Abstract][Full Text] [Related]
3. Anthracyclic products from Streptomyces erythromogenes nov. sp. Biotransformation of daunomycin (Dn) by an acellular preparation and synergism between Dn and some known antibiotics. Abdallah NM; Devys M; Barbier M Z Allg Mikrobiol; 1982; 22(3):155-60. PubMed ID: 7113265 [TBL] [Abstract][Full Text] [Related]
4. Biotransformations of anthracyclinones in Streptomyces coeruleorubidus and Streptomyces galilaeus. Blumauerová M; Královcová E; Matĕjů J; Jizba J; Vanĕk Z Folia Microbiol (Praha); 1979; 24(2):117-27. PubMed ID: 456946 [TBL] [Abstract][Full Text] [Related]
5. Microbial conversion of anthracyclinones to daunomycin by blocked mutants of Streptomyces coeruleorubidus. Yoshimoto A; Oki T; Takeuchi T; Umezawa H J Antibiot (Tokyo); 1980 Oct; 33(10):1158-66. PubMed ID: 7451367 [TBL] [Abstract][Full Text] [Related]
6. Microbial conversion of anthracycline antibiotics. II. Characterization of the microbial conversion products of auramycinone by Streptomyces coeruleorubidus ATCC 31276. Hoshino T; Fujiwara A J Antibiot (Tokyo); 1983 Nov; 36(11):1463-7. PubMed ID: 6654755 [TBL] [Abstract][Full Text] [Related]
7. Biosynthesis of daunorubicin glycosides: role of epsilon-rhodomycinone. McGuire JC; Thomas MC; Stroshane RM; Hamilton BK; White RJ Antimicrob Agents Chemother; 1980 Sep; 18(3):454-64. PubMed ID: 7425613 [TBL] [Abstract][Full Text] [Related]
8. Microbial conversion of daunomycin, carminomycin I and feudomycin A to adriamycin. Oki T; Takatsuki Y; Tobe H; Yoshimoto A; Takeuchi T; Umezawa H J Antibiot (Tokyo); 1981 Sep; 34(9):1229-31. PubMed ID: 7328065 [No Abstract] [Full Text] [Related]
9. Relative binding free energy calculations of DNA to daunomycin and its 13-dihydro analogue. Shi Y; Zhao H; Wang C Int J Biol Macromol; 1993 Aug; 15(4):247-51. PubMed ID: 8373745 [TBL] [Abstract][Full Text] [Related]
10. 7-Deoxy-13-dihydrodaunomycinone in cultures of Streptomyces coeruleorubidus. Matĕjů J; Vokoun J; Blumauerová M; Vanĕk Z Folia Microbiol (Praha); 1978; 23(3):246-8. PubMed ID: 669492 [TBL] [Abstract][Full Text] [Related]
11. Microbial transformation of semisynthetic derivatives of daunomycinone modified in ring A. Prikrylova V; Jizba J; Blumauerova M; Huk J; Sedmera P Folia Microbiol (Praha); 1989; 34(5):459-62. PubMed ID: 2630409 [TBL] [Abstract][Full Text] [Related]
12. Studies on the production of daunomycinone-derived glycosides and related metabolites in Streptomyces coeruleorubidus and Streptomyces peucetius. Blumauerová M; Matĕjů J; Stajner K; Vanĕk Z Folia Microbiol (Praha); 1977; 22(4):275-85. PubMed ID: 892669 [TBL] [Abstract][Full Text] [Related]
13. Isolation and characterization of a gene from Streptomyces sp. strain C5 that confers the ability to convert daunomycin to doxorubicin on Streptomyces lividans TK24. Dickens ML; Strohl WR J Bacteriol; 1996 Jun; 178(11):3389-95. PubMed ID: 8655530 [TBL] [Abstract][Full Text] [Related]
14. Production of new anthracycline antibiotics 1-hydroxy-oxaunomycin and 6-deoxyoxaunomycin by limited biosynthetic conversion using a daunorubicin-negative mutant. Yoshimoto A; Johdo O; Tone H; Okamoto R; Naganawa H; Sawa T; Takeuchi T J Antibiot (Tokyo); 1992 Oct; 45(10):1609-17. PubMed ID: 1473988 [TBL] [Abstract][Full Text] [Related]
15. [Leukaemomycin-blocked mutants of Streptomyces griseus and their pigments. III. 11-Desoxydaunomycinone derivatives from the mutant ZIMET 43699/G44]. Wagner C; Eckardt K; Tresselt D; Ihn W; Schumann G; Fleck WF J Basic Microbiol; 1985; 25(10):687-93. PubMed ID: 3937895 [TBL] [Abstract][Full Text] [Related]
16. Expression of doxorubicin-daunorubicin resistance genes in different anthracycline-producing mutants of Streptomyces peucetius. Colombo AL; Solinas MM; Perini G; Biamonti G; Zanella G; Caruso M; Torti F; Filippini S; Inventi-Solari A; Garofano L J Bacteriol; 1992 Mar; 174(5):1641-6. PubMed ID: 1537806 [TBL] [Abstract][Full Text] [Related]
17. Metabolism of the anthracycline antibiotic daunorubicin to daunorubicinol and deoxydaunorubicinol aglycone in hepatocytes isolated from the rat and the rabbit. Gewirtz DA; Yanovich S Biochem Pharmacol; 1986 Nov; 35(22):4059-64. PubMed ID: 3778526 [TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacology of daunorubicin. Benjamin RS Cancer Treat Rep; 1981; 65 Suppl 4():109-10. PubMed ID: 6955010 [No Abstract] [Full Text] [Related]
19. Microbial metabolism of anthracycline antibiotics daunomycin and adriamycin. Marshall VP; McGovren JP; Richard FA; Richard RE; Wiley PF J Antibiot (Tokyo); 1978 Apr; 31(4):336-42. PubMed ID: 26650 [TBL] [Abstract][Full Text] [Related]